Sutures India

About Sutures India

Established in 1992 by L.G. Chandrasekhar and S. Subramanian, Sutures India, now operating as Healthium Medtech, has become a significant force in the global medical devices market. The founders, both veterans of multinational medical device companies, launched the Bengaluru-based venture with a mission to produce high-quality, affordable surgical products for the Indian market. Initially focusing on catgut sutures, the company achieved operational profitability within its first year.

Over the decades, Healthium Medtech has strategically expanded its operations and product lines. It now operates in over 90 countries and serves a vast network of hospitals and surgeons. The business model is centered on the manufacturing and direct sale of a broad spectrum of medical consumables to healthcare institutions, including corporate and public hospitals and nursing homes. Revenue is generated through these sales, with the company reporting annual revenues of ₹845 Crore (approximately $102M) as of March 31, 2024. A pivotal moment in its history was the 2018 acquisition by private equity firm Apax Partners, which purchased a 99.8% stake, leading to the complete exit of the original promoters and a transition to a professionally managed entity.

Healthium Medtech's product portfolio is extensive, covering wound closure, infection prevention, and surgical care. The company manufactures a wide array of items including absorbable and non-absorbable sutures, surgical meshes, gloves, skin staplers, bone wax, and catheters. This comprehensive offering caters to numerous surgical specialties like general surgery, orthopedics, cardiovascular surgery, and gynecology. The company distinguishes itself as the largest non-captive surgical needles manufacturer by volume globally and the fourth-largest sutures manufacturer worldwide. Its products are used in one out of every five surgeries performed globally, underscoring its market penetration and scale.